+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Biopharma Outsourcing Market: By Services; By Geography - Forecast 2016-2021

  • ID: 3973717
  • Report
  • March 2016
  • 144 pages
  • IndustryARC
1 of 3
Biopharma outsourcing plays an important role in the growth of biopharmaceuticals market. The growth of this market is promising with rapidly expanding biosimilars base. With rising complexity of biologic drugs, the biosimilars become more important which pressurizes the investors and drug companies in terms of cost and quality. Biopharmaceutical manufacturers more often prefer custom manufacturing and research solutions from the outsourcing companies to meet the milestones in research and commercial pipeline. The selection of contract organizations depends on several factors including cost, technical capabilities, reliability, quality and their adherence to timelines. Driven by the aforementioned factors, this market is set to reach $XX billion, growing at a CAGR of XX% in the coming five years.

This market encompasses various contract companies that provide clinical trials, drug discovery, drug development, manufacturing, packaging, software and non-clinical services. Few provide end-to end solutions from trials to commercialization and pharmocovigilance. Whereas, few entities are specialized in particular activity. The biopharma outsourcing market has witnessed double digit growth in the past three years and this pace is set to continue with expanding biopharma research and need for innovative drugs. Quality and on-time delivery has become important factors apart from cost. Emerging biotech companies prefer integrated solution providers and are maintaining strategic partnerships in long run.

North America held a major share of XX% in this market, followed by APAC. APAC is poised to maintain significant growth primarily driven by expanding biopharmaceuticals industry and industry inclination towards low-cost quality manufacturing services. Market players are enhancing their technical and production capabilities to serve the biopharma companies. Competitive landscape for industry and market players is profiled in the report in detail.

The key players in biopharma outsourcing market include:

Sartorius AG
Emcure Pharmaceuticals Ltd
BioPharma Services Inc.

Quintiles Inc.

Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 3
1. Biopharma Outsourcing Market Overview
1.1. Introduction
1.2. Classification

2. Executive Summary

3. Biopharma Outsourcing Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. Patent Analysis
3.2.3. Financials of Key Players

4. Biopharma Outsourcing Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Industry
4.4.1. Suppliers Power
4.4.2. Bargaining Power of Buyer
4.4.3. Threat from New Entrants
4.4.4. Threats from Substitutes
4.4.5. Degree of Competition

5. Biopharma Outsourcing Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Opportunity Analysis
5.3. Biosimilars Market Landscape
5.4. Biopharmaceuticals Investment Analysis

6. Biopharma Outsourcing Market– By Service
6.1. Clinical Trials
6.2. Drug Discovery
6.3. API Development
6.4. Contract Production & Packaging
6.5. Non-Clinical Services
6.6. Others

7. Biopharma Outsourcing Market-Geographic Analysis
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.3. Europe
7.3.1. U.K.
7.3.2. Germany
7.3.3. France
7.3.4. Italy
7.3.5. Rest of Europe
7.4. APAC
7.4.1. China
7.4.2. Japan
7.4.3. India
7.4.4. Rest of APAC
7.5. RoW
7.5.1. South America
7.5.2. Middle East
7.5.3. Africa

8. Market Entropy

9. Company Profiles (Overview, Financials, Developments and Product Portfolio)
9.1. Sartorius AG
9.2. Emcure Pharmaceuticals Ltd
9.3. BioPharma Services Inc.
9.4. Lambda Therapeutic Research Ltd.
9.5. Baxter Healthcare Corporation
9.6. Keyrus Biopharma
9.7. Quintiles Inc.
9.8. Aptuit LLC
9.9. KBI Biopharm
9.10. ICON plc
9.11. Chiltern International Ltd.
9.12. Covance Inc.
9.13. GSK plc
9.14. Lonza
9.15. WuXi Biologics
9.16. Rentschler Biotechnologie GmbH
9.17. Cyprotex
9.18. Eurofins Scientific
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

10. Appendix
10.1. Abbreviations
10.2. Sources
10.3. Research Methodology
10.4. Bibliography
10.5. Compilation of Expert Insights
10.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 3


4 of 3